New and emerging treatments for stroke

British Medical Bulletin

Volumn 77-78, Issue 1, 2006, Pages 87-102

  Dawson, Jesse ^a   Walters, Matthew ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Haemostatic therapy; Neuroprotection; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE; DESMOTEPLASE; DISUFENTON SODIUM; FIBRINOLYTIC AGENT; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

ARTERY OCCLUSION; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CRANIECTOMY; EMBOLECTOMY; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HUMAN; HYPERTENSION; INTRACRANIAL PRESSURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; RECANALIZATION; REPERFUSION; REVIEW; STATISTICAL SIGNIFICANCE; STROKE PATIENT; TREATMENT OUTCOME;

ACUTE DISEASE; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROPROTECTIVE AGENTS; REPERFUSION; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33846200328     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldl011     Document Type: Review

References (67)

1. MacKay J, Mensah G. The Atlas of Heart Disease and Stroke. Oxford: World Health Organization Publication, Geneva, 2004.
2. Palmer AJ, Valentine WJ, Roze S et al. Overview of costs of stroke from published, incidence-based studies spanning 16 industrialised countries. Curr Med Res Opin 2005;21:19-27.
3. Vila EM, Irimia P. The cost of stroke. Cerebrovasc Dis 2004;17(Suppl 1):124-9.
4. Public Accounts Committee. Fifty second report. Reducing brain damage: faster access to better stroke care. http://www.publications.parliament.uk/pa/ cm200506/cmselect/cmpubacc/911/91102.htm (accessed 20 July 2006).
5. National Audit Office. Reducing brain damage: faster access to better stroke care. http://www.nao.org.uk/publications/nao_reports/05-06/0506452.pdf (accessed 20 July 2006).
6. Ginsberg MA, Pulsinelli W. The ischaemic penumbra, injury thresholds and the therapeutic window for acute stroke. Ann Neurol 1994;36:553-4.
7. Castillo J, Davalos A, Naviero J et al. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 1996;27:1060-5.
8. Brown RC, Davis TP. Calcium modulation of adherens and tight junction function; a potential mechanism for blood-brain barrier disruption after stroke. Stroke 2002;33:1706-11.
9. Kuroda S, Siesjo BK. Reperfusion damage following cerebral ischemia: pathophysiology and therapeutic windows. Clin Neurosci 1997;4:199-212.
10. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral haemorrhage, incidence and time course. Stroke 1996;27:1783-7.
11. Brott T, Broderick J, Kothari R et al. Early haemorrhage growth in patients with intracerebral haemorrhage. Stroke 1997;28:1-5.
12. Wardlaw JM, Keir SL, Seymour J et al. What is the best imaging strategy for acute stroke. Health Technol Assess 2004;8:1-180.
13. Wardlaw JM, Keir SL, Dennis MS. The impact of delays in computed tomography of the brain on the accuracy of diagnosis and subsequent management in patients with minor stroke. J Neurol Neurosurg Psych 2003;74:77-81.
14. Schlaug G, Benfield A, Baird AS et al. The ischaemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 1999;53:1528-37.
15. Wintermark M, Reichhart M, Thiran JP et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002;51:417-32.
16. Hankey GJ. Secondary prevention of recurrent stroke. Stroke 2005;36:218-21.
17. Stroke Unit Trialists' Collaberation. Organised inpatient (stroke unit) care for stroke (Cochrane Review). In The Cochrane Library, Issue 4, Oxford, 2002.
18. Stroke Unit Trialists' Collaboration. How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke 1997;28:2139-44.
19. Leonardi-Bee J, Bath PMW, Phillips SJ, Sandercock PAG for the IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002;33:1315-20.
20. Wilmot M, Leonardi-Bee J, Bath PMW. High blood pressure in acute stroke and subsequent outcome: a systematic review. Cerbrovasc Dis 2002;13(Suppl 3):95 (abstract).
21. Meyer JS, Shimazu K, Fukuuchi Y et al. Impaired neurogenic cerebrovascular control and dysautoregulation after stroke. Stroke 1973;4:169-86.
22. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after stroke? Results of a long term follow up study. BMJ 1997;314:1303-6.
23. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycaemia and prognosis in non-diabetic and diabetic patients - a systematic overview. Stroke 2001;32:2426-32.
24. Parsons MW, Barber PA, Desmond PM et al. Acute hyperglycaemia adversely affects stroke outcome: a magnetic resonance imaging and spectroiscopy study. Annal Neurol 2002;52:20-8.
25. Ribo M, Molina C, Montaner J et al. Acute hyperglycaemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke 2005;36:1705-9.
26. Royal College of Physicians. National Clinical Guidelines for Stroke. London: Royal College of Physicians, 2004.
27. Adams HP, Adams RJ, Brott T et al. Guidelines for early management of patients with ischaemic stroke. A scientific statement from the council of the American Stroke Association. Stroke 2003;34:1056.
28. Hajat C, Hajat S, Sharma P. Effects of post stroke pyrexia on stroke outcome: a meta-analysis on stroke mortality. Stroke 2000;31:410- 4.
29. Globus MY, Busto R, Lin B, Schnippering H, Ginsberg MD. Detection of free radical activity during transient global amnesia and recirculation; effects on intra-ischemic brain temperatures and modulation. J Neurochem 1995;65:1250-6.
30. Dietrich WD, Halley M, Valdes I, Busto R. Interrelationships between increased vascular permeability and acute neuronal damage following temperature controlled brain ischaemia in rats. Acta Neuropathol (Berl) 1991;81:615-25.
31. Azzimondi G, Bassein L, Fiorani L et al. Variables associated with hospital arrival time after stroke: effect of delay on the clinical efficiency of early treatment. Stroke 1997;28:537-42.
32. Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS and NINDS rt-PA stroke trials. Lancet 2004;363:763-74.
33. Saver J. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol 2004;61:1066- 70.
34. Tanne D, Kasner SE, Demchuk AM et al. Markers of increased risk of intracerebral haemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischaemic stroke in clinical practice: the multi-center rt-PA stroke survey. Circulation 2005;105:1679-85.
35. Hill AD, Buchan AM. Thrombolysis for acute ischaemic stroke: results of the Canadian Alteplase for Stroek Effectiveness Study. CMAJ 2005;10:1307-12.
36. Furlan A, Higashida R, Wechsler L et al. Intra-arterial thrombolysis for acute ischaemic stroke. The PROACT II study: a randomised controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003-11.
37. Arnold M, Nedeltchev K, Schroth G et al. Clinical and radiological predictors of recanalisation and outome of 40 patients with acute basilar artery occlusion treated with intraarterial thrombolysis. J Neurol Neurosurg Psych 2004;75:857-62.
38. Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion. A systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke 2006;37:922-8.
39. Bergui M, Stura G, Daniele D, Cerrato P, Berardino M, Bradac GB. Mechanical thrombolysis in ischemic stroke attributable to basilar artery occlusion as first line treatment. Stroke 2006;37:145-50.
40. Smith WS, Sung G, Starkman S et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke. Stroke 2005;36:1432-8.
41. Hacke W, Albers G, Al-Rawi Y et al. The Desmoteplase in Acute Iscaemic Stroke Trial: a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:63-73.
42. Furlan AJ, Eyding D, Albers GW et al. Dose escalation of desmoteplase for acute ischaemic stroke (DEDAS). Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227.
43. Maples KR, Ma F, Zhang Y-K. Comparison of the free radical trapping ability of PBN, D-PPBN and NXY-059. Free Radic Res 2001;34:417-26.
44. Lees KR, Zivin JA, Ashwood T et al. For the Stroke-Acute Ischemic-NXY Treatment (SAINT I) trial investigators: NXY-059 for acute ischaemic stroke. NEJM 2006;354:588-600.
45. Young FB, Weir CJ, Lees KR. Comparison of the NIHSS with disability outcome measures in acute stroke trials. Stroke 2005;36:2187-92.
46. Weimar C, Kurth T, Kraywinkel K. Assessment of functioning and disability after ischaemic stroke. Stroke 2002;33:2053-9.
47. Correia M, Silva M, Veloso M. Cooling therapy for acute stroke (Cochrane Review). The Cochrane Library, Issue 3, Oxford, 2006.
48. Lanier WL. Cerebral metabolic rate and hypothermia: their relationship with ischaemic neurologic injury. J Neurosurg Nesthesiol 1995;7:216-21.
49. Hammer MD, Krieger DW. Acute ischemic stroke: Is there a role for hypothermia? Cleve Clin J Med 2002;69:770-85.
50. Kammersgaard L, Rasmussen B, Jorgensen H, Reith J, Weber U, Olsen T. Feasibility and safety of inducing mild hypothermia in awake patients with acute stroke using surface cooling. Stroke 2000;31:2251-6.
51. Guluma KZ, Hemmen TM, Olsen SE, Rapp KS, Lyden PD. A trial of therapeutic hypothremia via endovascular approach in awake patients with acute ischaemic stroke: methodology. Acad Emerg Med 2006;1:820-7.
52. Schwab S, Georgiadis D, Berrouschot J, Schellinger PD, Graffagnino C, Mayer S. Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke 2001;32:2033.
53. Krieger DW, Yenari AM. Therapeutic hypothermia for acute ischaemic stroke: What do laboratory studies teach us? Stroke 2004;35:1482- 9.
54. Morikawa E, Ginsberg MD, Dietrich WD et al. The significance of brain temperature in focal cerebral iscaemia: histopathological consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1992;12:380-9.
55. Ridenour TR, Warner DS, Todd MM, McAllister AC. Mild hypothermia reduces infarct size resulting from temporary but not permanent focal ischaemia in rats. Stroke 1992;23:733-8.
56. Maier CM, Ahern K, Cheng ML, Lee JE, Yenari MA, Steinberg GK. Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischaemia: effects on neurologic outcome, infarct size, apoptosis, and inflammation. Stroke 1998;29:2171-80.
57. Berger C, Schramm P, Schwab S. Reduction of diffusion-weighted MRI lesion volume after early moderate hypothermia in ischemic stroke. Stroke 2005;36:e56.
58. Krieger DW, Georgia MA, Chebl AA et al. Cooling for acute ischaemic brain damage. Stroke 2001;32:1847-54.
59. Hart RG, Boop BS, Anderson DC. Oral anticoagulant use and intracranial haemorrhage: facts and hypotheses. Stroke 1995;26:1471-7.
60. Fredriksson B, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracerebral haemorrhage. Stroke 1992;23:972-7.
61. Mayer SA, Brun NC, Begtrup K et al. Recombinant activated factor VII for acute intracerebral haemorrhage. NEJM 2005;352:777-85.
62. Counsell C, Boonyakarnkul S, Dennis M et al. Primary intracerebral hemorrhage in the Oxfordshire Community Stroke Project. Cerebrovasc Dis 1995;5:26-34.
63. Gupta R, Connelly ES, Mayer S, Elkind MS. Hemicraniectomy for massive middle cerebral artery infarction, a systematic review. Stroke 2004;35:539-43.
64. Cho DY, Chen TC, Lee HC. Ultra-early decompressive craniectomy for malignant middle cerebral artery infarction. Surg Neurol 2003;60:227-32.
65. Schwab S, Steiner T, Aschoff A et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998;29:1888-93.
66. Schwab S, Jüttler E. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY). Stroke 2005;36:e59-67.
67. Marmattom BV, Bahn MM, Wijdicks EFM. Which patients fare worse after early deterioration due to swelling from hemispheric stroke? Neurology 2004;63:2142-5.